Officer

Forrest Hoffmaster, a seasoned executive with a wealth of experience in the cannabis industry, has been appointed as the interim...

Ron Bruehlman, the Chief Financial Officer (CFO) of IQVIA, a leading global provider of advanced analytics, technology solutions, and contract...

Fintech Singapore Welcomes Cybersecurity Expert John Yong to NETS Board Singapore’s fintech industry has recently welcomed cybersecurity expert John Yong...

Welcome to our weekly roundup of the top SaaStr content! In this edition, we bring you an exclusive interview with...

Executive Moves of the Week: Notable Appointments at Options Technology, Barchart, and Mastercard In the fast-paced world of business, executive...

Important Information for CISOs: Exploring CIO Convergence, Essential Security Metrics, and the Impact of Ivanti Fallout In today’s rapidly evolving...

As the role of Chief Information Security Officer (CISO) continues to evolve in today’s rapidly changing digital landscape, it is...

Xsolla, a leading global video game commerce company, has recently announced a new leadership structure aimed at driving strategic growth...

Valtteri Lahtinen, a prominent figure in the field of quantum technology, is set to speak at the upcoming IQT Nordics...

Integer Holdings Corporation, a leading medical device outsource manufacturer, recently announced its financial results for the fourth quarter and fiscal...

Zoomcar’s Greg Morgan Shares Fun Ways to Make the Experience Memorable for Customers on Indian Television In today’s fast-paced world,...

Understanding the Intersection of CISO Responsibilities, Department of Defense Regulations, Neurodiverse Talent, and Tel Aviv’s Light Rail System In today’s...

Orexa Commences Phase 2 Trial in Post-Operative Patients with First Patient Dosed – Drugs.com MedNews Orexa Pharmaceuticals, a leading biopharmaceutical...

Tim Solms Appointed as CEO of Slingshot Aerospace, a Leading Tech Company in the Aerospace Industry Slingshot Aerospace, a prominent...

Phase I Thromboembolic Disorder Trial Commences Subject Dosing by Sirius Sirius Pharmaceuticals, a leading biopharmaceutical company, has announced the commencement...